Recombinant Yeast Vanillin Production Byproduct Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The production of natural vanillin from vanilla pods is laborious and inefficient, resulting in only a small percentage of global vanillin supply, while chemically synthesized vanillin is cheaper and more abundant, leading to inefficiencies in downstream purification due to byproduct vanillic alcohol accumulation.

Innovation Solution

A recombinant yeast host with reduced activity of specific alcohol dehydrogenases and aldehyde reductases is engineered to produce vanillin or vanillin beta-D-glucoside, utilizing genes such as O-methyltransferase, 3-dehydroshikimate dehydratase, and uridine 5'-diphosphoglucosyl transferase, and employing genetic modification techniques like gene deletion or promoter modification to minimize byproduct formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemically synthesized vanillin is produced from lignin or fossil hydrocarbons, then production cost is reduced and abundance is increased, but downstream purification efficiency deteriorates due to byproduct vanillic alcohol accumulation

Engineering Contradiction:
Improveproduction efficiencyVSAvoidbyproduct accumulation
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and removes the harmful byproduct formation pathway by deleting specific genes (ADH6, ADH7, GRE2, ARI1, YGL039W) that encode enzymes responsible for converting vanillin to vanillic alcohol. This eliminates the harmful side reaction while preserving the main vanillin production pathway, thereby improving purification efficiency without sacrificing productivity

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the metabolic parameters of the yeast host by modifying gene expression levels and enzyme activities. By reducing or eliminating the activity of specific dehydrogenases and reductases, the metabolic flux is redirected to favor vanillin accumulation over vanillic alcohol formation, thus resolving the contradiction between high productivity and low byproduct formation

Inventive Principle:
Principle #35Parameter changes

2Reliability

If natural vanillin is produced from vanilla pods through traditional methods, then product purity is maintained, but production time and labor requirements increase significantly

Engineering Contradiction:
Improveproduct qualityVSAvoidproduction time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces the mechanical and manual processes of traditional vanilla pod processing (hand pollination, harvesting, curing) with a biological system - genetically engineered yeast cells. These yeast cells perform the chemical transformations needed to produce vanillin through metabolic pathways, substituting months of manual labor and curing time with a controlled fermentation process that achieves the same result in a fraction of the time while maintaining product quality

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Object-generated harmful factors

If genes encoding alcohol dehydrogenases and aldehyde reductases are deleted to reduce byproduct formation, then downstream purification efficiency is improved, but metabolic pathway completeness deteriorates

Engineering Contradiction:
Improvebyproduct formationVSAvoidmetabolic pathway stability
Core Design Contradiction:
Object-generated harmful factorsVSStability of the object's composition

Solution Approach 1:

The patent applies local quality modification by selectively deleting only the specific genes (ADH6, ADH7, GRE2, ARI1, YGL039W) that are responsible for vanillic alcohol formation, while leaving the rest of the metabolic pathway intact. This targeted approach ensures that only the harmful side reaction is eliminated while the overall metabolic stability and vanillin production capability are preserved

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs feedback control by monitoring the metabolic flux and adjusting the genetic modifications accordingly. By identifying and deleting only the enzymes that cause byproduct accumulation while maintaining the essential vanillin synthesis pathway, the system achieves optimal balance between byproduct reduction and metabolic stability

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances vanillin production efficiency by reducing byproduct vanillic alcohol accumulation, facilitating more efficient downstream purification and potentially lowering production costs, thereby improving the economic viability of natural vanillin production.

Implementation Method 1

a nucleic acid encoding an O-methyltransferase (OMT) polypeptide

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

a nucleic acid encoding a 3-dehydroshikimate dehydratase (3DSD) polypeptide

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

a nucleic acid encoding an uridine 5'-diphosphoglucosyl transferase (UGT) polypeptide

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 4

the recombinant host has, compared to a wild-type organism, reduced production or activity of: (i) Alcohol Dehydrogenase 6 (ADH6), Aldehyde Reductase Intermediate 1 (ARI1), and Aldehyde Reductase YGL039W

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Data Source

PatentEP3022291B1Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside
Publication Date: 2023.06.07 INTERNATIONAL FLAVORS & FRAGRANCES INC
  • EP3022291B1 patent drawingFigure 1
  • EP3022291B1 patent drawingFigure 2~3

AI summary

Recombinant microorganisms, plants, and plant cells are disclosed that have been engineered to have reduced levels or activity of one or more alcohol dehydrogenases or aldehyde reductase thereby increasing the production of vanillin or vanillin beta-D-glucoside.